Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Akums Drugs will undertake this development and commercialization in India
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
Aims to achieve CDMO sales of US$ 400 million by 2028
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Subscribe To Our Newsletter & Stay Updated